Yorktown Management & Research Company’s Guardant Health GH Stock Holding History

Yorktown Management & Research Company’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88M	Buy	12,500 +3,650	+41%	+$397K	1.15%	7
2026 Q1	$817K	Buy	8,850 +3,300	+59%	+$331K	0.68%	35
2025 Q4	$567K	Hold	5,550	–	–	0.45%	76
2025 Q3	$347K	Hold	5,550	–	–	0.28%	149
2025 Q2	$289K	Buy	+5,550	New	+$248K	0.28%	172

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Yorktown Management & Research Company's GH Position: Q2 2026 in Review

Yorktown Management & Research Company increased its Guardant Health (GH) stake by 41% in Q2 2026, buying an estimated $397K and bringing the position to 12,500 shares worth $1.88M. The position accounts for 1.15% of the portfolio, ranked #7.

Yorktown Management & Research Company first reported a position in GH in Q2 2025 and has held it in 5 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Yorktown Management & Research Company held 12,500 shares of Guardant Health worth $1.88M as of Q2 2026.
Yorktown Management & Research Company bought 3,650 Guardant Health shares in Q2 2026, an estimated $397K.
Guardant Health made up 1.15% of Yorktown Management & Research Company's portfolio in Q2 2026, its #7 holding.
Yorktown Management & Research Company first reported a position in Guardant Health in Q2 2025 and has held it in 5 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Yorktown Management & Research Company's 13F filing for Q2 2026, filed 23 Jul 2026.